» Articles » PMID: 22847295

A Possible Cross-talk Between Autophagy and Apoptosis in Generating an Immune Response in Melanoma

Overview
Journal Apoptosis
Publisher Springer
Date 2012 Aug 1
PMID 22847295
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Melanoma is the most aggressive form of skin cancer, responsible for the majority of skin cancer related deaths. Thus, the search for natural molecules which can effectively destroy tumors while promoting immune activation is essential for designing novel therapies against metastatic melanoma. Here, we report for the first time that a natural triterpenoid, Ganoderic acid DM (GA-DM), induces an orchestrated autophagic and apoptotic cell death, as well as enhanced immunological responses via increased HLA class II presentation in melanoma cells. Annexin V staining and flow cytometry showed that GA-DM treatment induced apoptosis of melanoma cells, which was supported by a detection of increased Bax proteins, co-localization and elevation of Apaf-1 and cytochrome c, and a subsequent cleavage of caspases 9 and 3. Furthermore, GA-DM treatment initiated a possible cross-talk between autophagy and apoptosis as evidenced by increased levels of Beclin-1 and LC3 proteins, and their timely interplay with apoptotic and/or anti-apoptotic molecules in melanoma cells. Despite GA-DM's moderate cytotoxicity, viable cells expressed high levels of HLA class II proteins with improved antigen presentation and CD4+ T cell recognition. The antitumor efficacy of GA-DM was also investigated in vivo in murine B16 melanoma model, where GA-DM treatment slowed tumor formation with a significant reduction in tumor volume. Taken together, these findings demonstrate the potential of GA-DM as a natural chemo-immunotherapeutic capable of inducing a possible cross-talk between autophagy and apoptosis, as well as improved immune recognition for sustained melanoma tumor clearance.

Citing Articles

Autophagy and Programmed Cell Death Modalities Interplay in HIV Pathogenesis.

Lamsira H, Sabatini A, Ciolfi S, Ciccosanti F, Sacchi A, Piacentini M Cells. 2025; 14(5).

PMID: 40072080 PMC: 11899401. DOI: 10.3390/cells14050351.


Using a Natural Triterpenoid to Unlock the Antitumor Effects of Autophagy in B-Cell Lymphoma.

Doonan B, Radwan F, Banik N, Haque A Biomedicines. 2025; 13(2).

PMID: 40002858 PMC: 11853664. DOI: 10.3390/biomedicines13020445.


Progress in Antimelanoma Research of Natural Triterpenoids and Their Derivatives: Mechanisms of Action, Bioavailability Enhancement and Structure Modifications.

Grudzinska M, Stachnik B, Galanty A, Soltys A, Podolak I Molecules. 2023; 28(23).

PMID: 38067491 PMC: 10707933. DOI: 10.3390/molecules28237763.


Inhibitory effects of Ganoderma lucidum triterpenoid on the growth and metastasis of hepatocellular carcinoma.

Ding Z, Zhou Z, Cheng X, Wang H, Liu J, Cai Y Am J Transl Res. 2023; 15(5):3410-3423.

PMID: 37303681 PMC: 10251039.


: Unutilized natural medicine and promising future solution to emerging diseases in Africa.

Oke M, Afolabi F, Oyeleke O, Kilani T, Adeosun A, Olanbiwoninu A Front Pharmacol. 2022; 13:952027.

PMID: 36071846 PMC: 9441938. DOI: 10.3389/fphar.2022.952027.


References
1.
Rigel D, Russak J, Friedman R . The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin. 2010; 60(5):301-16. DOI: 10.3322/caac.20074. View

2.
KERR J, Winterford C, Harmon B . Apoptosis. Its significance in cancer and cancer therapy. Cancer. 1994; 73(8):2013-26. DOI: 10.1002/1097-0142(19940415)73:8<2013::aid-cncr2820730802>3.0.co;2-j. View

3.
Elmore S . Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35(4):495-516. PMC: 2117903. DOI: 10.1080/01926230701320337. View

4.
Gannage M, Munz C . Autophagy in MHC class II presentation of endogenous antigens. Curr Top Microbiol Immunol. 2009; 335:123-40. DOI: 10.1007/978-3-642-00302-8_6. View

5.
Mizushima N, Komatsu M . Autophagy: renovation of cells and tissues. Cell. 2011; 147(4):728-41. DOI: 10.1016/j.cell.2011.10.026. View